Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: General physical health deterioration; This is a spontaneous report from a non-contactable physician downloaded from the Medicines Agency (MA) Regulatory Authority-WEB, Regulatory Authority number DE-PEI-PEI2021002561. A 98-year-old male patient received the second dose bnt162b2 (COMIRNATY), intramuscular on 03Feb2021 at SINGLE DOSE for covid-19 immunisation. The patient''s medical history and concomitant medications were not reported. The patient previously received the first dose bnt162b2 (COMIRNATY) in Jan2021 for covid-19 immunization, and had been tolerated. On 05Feb2021 after vaccination the patient developed general physical health deterioration, lasting for 5 days. No treatment, no hospitalization. The patient died in Feb2021. It was not reported if an autopsy was performed. The outcome of event general physical health deterioration was fatal. Event Assessment: For both events / RA / D. Unclassifiable. No follow-up attempts possible, batch/lot number cannot be obtained.; Reported Cause(s) of Death: General physical health deterioration
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166